MedPath

TETRABENAZINE

These highlights do not include all the information needed to use TETRABENAZINE tablets safely and effectively. See full prescribing information for TETRABENAZINE tablets TETRABENAZINE tablets, for oral useInitial U.S. Approval: 2008

Approved
Approval ID

b041d7a5-a678-4f80-8d78-a42d3d003fbc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 30, 2019

Manufacturers
FDA

TAGI Pharma, Inc.

DUNS: 963322560

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TETRABENAZINE

PRODUCT DETAILS

NDC Product Code51224-425
Application NumberANDA207682
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 30, 2019
Generic NameTETRABENAZINE

INGREDIENTS (5)

TETRABENAZINEActive
Quantity: 12.5 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

TETRABENAZINE

PRODUCT DETAILS

NDC Product Code51224-426
Application NumberANDA207682
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 30, 2019
Generic NameTETRABENAZINE

INGREDIENTS (6)

TETRABENAZINEActive
Quantity: 25 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.